Houlihan Lokey Advises Q-Centrix

Houlihan Lokey is pleased to announce that Q-Centrix, a portfolio company of Sterling Partners, has been acquired by TPG Growth. The transaction closed on November 30, 2018.

Headquartered in Chicago, Illinois, Q-Centrix is a leading provider of quality data management solutions to hospitals. The company aims to measurably improve the quality and safety of patient care in the U.S. through the use of its market-leading technology platform, Q-Apps, that augments the clinical intelligence and efficiency of the industry's largest and broadest team of nurse-educated Quality Information Specialists. Processing in excess of two million quality data transactions annually, Q-Centrix is a comprehensive quality partner to hundreds of hospitals, providing quality data capture, surveillance, measure calculations, analysis, reporting, and improvement solutions.

Founded in 1983, Sterling Partners is a diversified investment management firm based in Chicago. The firm invests in a wide variety of companies in various stages of growth—from early stage, high-growth businesses to mature, profitable companies—across several industries, and also backs managers across an array of asset classes. The firm makes control, non-control, and preferred equity investments with both internal and third-party capital. Sterling Partners provides valuable support to the management teams of the companies in which the firm invests through a deep and dedicated team of professionals, including a strong network of outside directors and advisors.

TPG Growth is the middle market and growth equity investment platform of TPG, the global alternative asset firm. With approximately $13.5 billion of assets under management, TPG Growth targets investments in a broad range of industries and geographies. TPG Growth has deep sector knowledge, operational resources, and global experience to drive value creation and help companies reach their full potential. The firm is backed by the resources of TPG, which has more than $94 billion of assets under management.

This transaction represents Houlihan Lokey's continued leadership and momentum in the healthcare technology and tech-enabled services sector, having advised on 23 transactions since 2015. Houlihan Lokey's Healthcare Group is among the largest dedicated healthcare investment banking groups in the country. In 2017, the group closed 21 transactions and was ranked the No. 1 advisor for U.S. healthcare M&A transactions under $1 billion by Thomson Reuters. Houlihan Lokey's Healthcare Group has closed more than 300 M&A healthcare transactions since inception.

Houlihan Lokey served as the exclusive financial advisor to Q-Centrix and assisted in initiating, structuring, and negotiating the transaction on its behalf. 


You are about to leave
Houlihan Lokey's website

The link below leads to a website that is not
owned by Houlihan Lokey.

Continue to the external website,
close the window to remain on HL.com